Primary Site >> Stomach Cancer
Gene >> VHL
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. PMID: 9973227 |
Ref: Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. PMID: 11238683 Ref: Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. PMID: 11413518 |
Ref: Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. PMID: 12692837 Ref: Tumour suppressor gene expression correlates with gastric cancer prognosis. PMID: 12692839 |
Ref: Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. PMID: 15303276 |
Ref: Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. PMID: 16395716 Ref: Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. PMID: 16557436 |
Ref: Genetic and epigenetic analysis of the VHL gene in gastric cancers. PMID: 18607865 |
Ref: Mutational analysis of hypoxia-related genes HIF1alpha and CUL2 in common human cancers. PMID: 20078552 |
Ref: 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug. PMID: 23817168 |
Ref: Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy. PMID: 25012543 |